168 related articles for article (PubMed ID: 7633657)
1. Culturing of cells from giant cell tumour of bone on natural and synthetic calcified substrata: the effect of leukaemia inhibitory factor and vitamin D3 on the resorbing activity of osteoclast-like cells.
Soueidan A; Gan OI; Gouin F; Godard A; Heymann D; Jacques Y; Daculsi G
Virchows Arch; 1995; 426(5):469-77. PubMed ID: 7633657
[TBL] [Abstract][Full Text] [Related]
2. Presence of leukaemia inhibitory factor (LIF) and LIF-receptor chain (gp190) in osteoclast-like cells cultured from human giant cell tumour of bone. Ultrastructural distribution.
Gouin F; Couillaud S; Cottrel M; Godard A; Passuti N; Heymann D
Cytokine; 1999 Apr; 11(4):282-9. PubMed ID: 10328867
[TBL] [Abstract][Full Text] [Related]
3. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture.
Van Beek E; Van der Wee-Pals L; van de Ruit M; Nijweide P; Papapoulos S; Löwik C
J Bone Miner Res; 1993 Feb; 8(2):191-8. PubMed ID: 8442437
[TBL] [Abstract][Full Text] [Related]
4. Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone.
Atkins GJ; Bouralexis S; Haynes DR; Graves SE; Geary SM; Evdokiou A; Zannettino AC; Hay S; Findlay DM
Bone; 2001 Apr; 28(4):370-7. PubMed ID: 11336917
[TBL] [Abstract][Full Text] [Related]
5. Increased osteoclastic differentiation by PMMA particle-associated macrophages. Inhibitory effect by interleukin 4 and leukemia inhibitory factor.
Sabokbar A; Fujikawa Y; Brett J; Murray DW; Athanasou NA
Acta Orthop Scand; 1996 Dec; 67(6):593-8. PubMed ID: 9065074
[TBL] [Abstract][Full Text] [Related]
6. The mouse mammary tumor cell line, MMT060562, produces prostaglandin E2 and leukemia inhibitory factor and supports osteoclast formation in vitro via a stromal cell-dependent pathway.
Akatsu T; Ono K; Katayama Y; Tamura T; Nishikawa M; Kugai N; Yamamoto M; Nagata N
J Bone Miner Res; 1998 Mar; 13(3):400-8. PubMed ID: 9525340
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone.
Richards CD; Langdon C; Deschamps P; Pennica D; Shaughnessy SG
Cytokine; 2000 Jun; 12(6):613-21. PubMed ID: 10843736
[TBL] [Abstract][Full Text] [Related]
8. The effect of leukemia inhibitory factor on bone in vivo.
Cornish J; Callon K; King A; Edgar S; Reid IR
Endocrinology; 1993 Mar; 132(3):1359-66. PubMed ID: 8440191
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of interleukin-6 receptor activation on intracellular signaling and bone resorption by isolated rat osteoclasts.
Moonga BS; Adebanjo OA; Wang HJ; Li S; Wu XB; Troen B; Inzerillo A; Abe E; Minkin C; Huang CL; Zaidi M
J Endocrinol; 2002 Jun; 173(3):395-405. PubMed ID: 12065229
[TBL] [Abstract][Full Text] [Related]
10. Leukaemia inhibitory factor and bone cell function.
Martin TJ; Allan EH; Evely RS; Reid IR
Ciba Found Symp; 1992; 167():141-50; discussion 150-5. PubMed ID: 1425010
[TBL] [Abstract][Full Text] [Related]
11. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.
Huang L; Xu J; Wood DJ; Zheng MH
Am J Pathol; 2000 Mar; 156(3):761-7. PubMed ID: 10702390
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone.
Mak IW; Seidlitz EP; Cowan RW; Turcotte RE; Popovic S; Wu WC; Singh G; Ghert M
Hum Pathol; 2010 Sep; 41(9):1320-9. PubMed ID: 20573369
[TBL] [Abstract][Full Text] [Related]
13. Cytokines expressed in multinucleated cells: Paget's disease and giant cell tumors versus normal bone.
Mills BG; Frausto A
Calcif Tissue Int; 1997 Jul; 61(1):16-21. PubMed ID: 9192505
[TBL] [Abstract][Full Text] [Related]
14. Upmodulation of multinucleated cell formation in long-term human bone marrow cultures by leukaemia inhibitory factor (LIF).
Heymann D; Gouin F; Guicheux J; Munevar JC; Godard A; Daculsi G
Cytokine; 1997 Jan; 9(1):46-52. PubMed ID: 9067095
[TBL] [Abstract][Full Text] [Related]
15. Effects of synthetic peptido-leukotrienes on bone resorption in vitro.
Garcia C; Qiao M; Chen D; Kirchen M; Gallwitz W; Mundy GR; Bonewald LF
J Bone Miner Res; 1996 Apr; 11(4):521-9. PubMed ID: 8992883
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone stimulatory effects on osteoclastic resorption are partly mediated by insulin-like growth factor I: an in vitro study.
Guicheux J; Heymann D; Rousselle AV; Gouin F; Pilet P; Yamada S; Daculsi G
Bone; 1998 Jan; 22(1):25-31. PubMed ID: 9437510
[TBL] [Abstract][Full Text] [Related]
17. Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-factor): regulation of its production and possible roles in bone metabolism.
Ishimi Y; Abe E; Jin CH; Miyaura C; Hong MH; Oshida M; Kurosawa H; Yamaguchi Y; Tomida M; Hozumi M
J Cell Physiol; 1992 Jul; 152(1):71-8. PubMed ID: 1618924
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Study of the Effects of Denosumab on Giant Cell Tumor of Bone: Comparison with Zoledronic Acid.
Shibuya I; Takami M; Miyamoto A; Karakawa A; Dezawa A; Nakamura S; Kamijo R
Pathol Oncol Res; 2019 Jan; 25(1):409-419. PubMed ID: 29159783
[TBL] [Abstract][Full Text] [Related]
19. Effects of leukemia inhibitory factor on bone resorption and DNA synthesis in neonatal mouse calvaria.
Lowe C; Cornish J; Martin TJ; Reid IR
Calcif Tissue Int; 1991 Dec; 49(6):394-7. PubMed ID: 1818764
[TBL] [Abstract][Full Text] [Related]
20. Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption.
Greenfield EM; Shaw SM; Gornik SA; Banks MA
J Clin Invest; 1995 Sep; 96(3):1238-44. PubMed ID: 7657797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
